Shareholder

Electra Announces Voting Results of its 2022 Annual Meeting of Shareholders

Retrieved on: 
Friday, November 11, 2022
Environment, Automotive, General Automotive, Public Relations, Investor Relations, Environmental Issues, Other Energy, Communications, Energy, Mining, Minerals, Natural Resources, SEDAR, Company, Leyland Royal Tiger PSU, Risk, Board, Consolidation, Ownership, Circular, Meeting, Motivation, TSX Venture Exchange, Cobalt, Terminology, View, Shareholder, Culture, Indian stock exchange, RSU, Forward-looking statement, Private Securities Litigation Reform Act, Intention, LTIP, News, Social Democrats (Slovenia)

At the Meeting, shareholders also approved an amended and restated Long-Term Incentive Plan (the 2022 LTIP), as described in the Circular.

Key Points: 
  • At the Meeting, shareholders also approved an amended and restated Long-Term Incentive Plan (the 2022 LTIP), as described in the Circular.
  • Shareholders also approved a new Employee Share Purchase Plan for the Company (the ESP Plan).
  • The 2022 LTIP and ESP Plan were conditionally approved by the TSXV on September 29, 2022 and remain subject to final acceptance of the TSXV.
  • The Companys full voting results at the meeting are available on SEDAR.

The Estée Lauder Companies 2022 Annual Meeting of Stockholders to Be Held on November 18, 2022

Retrieved on: 
Friday, November 11, 2022
Cosmetics, Retail, Webcast, Shareholder, EL, PARIS, Origin, NIOD, Beauty, Aveda, Skin care, NYSE, Koehler Instrument Company, Inc., Cosmetics

The Este Lauder Companies Inc. (NYSE: EL) will hold its 2022 Annual Meeting of Stockholders virtually on Friday, November 18, 2022 beginning at 10:00 a.m. (ET).

Key Points: 
  • The Este Lauder Companies Inc. (NYSE: EL) will hold its 2022 Annual Meeting of Stockholders virtually on Friday, November 18, 2022 beginning at 10:00 a.m. (ET).
  • For further information on the meeting, The Este Lauder Companies proxy statement materials and other information are available at www.elcompanies.com/investors .
  • Following the annual meeting, a webcast of the meeting will be available for replay on www.elcompanies.com/investors .
  • The Este Lauder Companies Inc. is one of the worlds leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products.

Creatd to Present Uplisting Plan at Annual Shareholder Meeting

Retrieved on: 
Friday, November 11, 2022
CEO, Acquisition, Annual Meetings of the International Monetary Fund and the World Bank Group, Ecosystem, Technology, NEW, Annual general meeting, Growth, OTCQB, Q&A, CRTD, Intention, Security (finance), Management, Shareholder

Company to hold its 2022 shareholders' meeting on January 9, 2023, with registration details to be announced.

Key Points: 
  • Company to hold its 2022 shareholders' meeting on January 9, 2023, with registration details to be announced.
  • Management to present on anticipated timeline in its pursuit of a re-listing to a national exchange.
  • NEW YORK, Nov. 11, 2022 /PRNewswire/ -- Creatd, Inc. (OTCQB: CRTD) ("Creatd" or the "Company"), a creator-first technology company, today is announcing its upcoming 2022 Annual Meeting of Stockholders (the "Annual Meeting"), to be held on January 9, 2023.
  • Shareholders of record as of the close of business on November 18, 2022, are entitled to notice of, and to vote at, the Annual Meeting and at any adjournment thereof.

Global Bioenergies renews equity line with Kepler Cheuvreux to support industrial deployment

Retrieved on: 
Friday, November 11, 2022
Kepler, Carbon, Company, Climate, Aviation, Solution, Shareholder, Cosmetics, Mass meeting, AMF, Prospectus, Global Bioenergies, CO2, Kepler Cheuvreux, Time, SPV, Renewable energy, Security (finance)

Global Bioenergies today announces the renewal of its equity line with Kepler Cheuvreux, a leading European financial services company acting as ISP1 as part of an underwriting agreement.

Key Points: 
  • Global Bioenergies today announces the renewal of its equity line with Kepler Cheuvreux, a leading European financial services company acting as ISP1 as part of an underwriting agreement.
  • This financing solution with Kepler Cheuvreux has already been a well-proven success for GlobalBioenergies: the two-year contract signed in August 2020 raised 13.6 million and the valuation of Global Bioenergies doubled over the same period.
  • These conditions allow Kepler Cheuvreux, acting as financial intermediary, to guarantee the subscription of shares throughout the term of the agreement.
  • In the long run, Global Bioenergies is also aiming at cutting CO2 emissions in the aviation and road sector and thereby curb global warming.

Integrated Rail and Resources Acquisition Corp. Announces Extension

Retrieved on: 
Friday, November 11, 2022
Other Professional Services, Professional Services, Business, Finance, Transfer, Securities Act of 1933, Industry, Shareholder, Company, Board, Special, Rail transport by country, Acquisition, Business architecture, LLC, Trust, Natural Resources

The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

Key Points: 
  • The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
  • While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on natural resources, railroads and/or railroad logistics companies, or any combinations thereof.
  • The Company is sponsored by DHIP Natural Resources Investments, LLC.
  • This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.

Retrieved on: 
Thursday, November 10, 2022
Food and Drug Administration Amendments Act of 2007, Ix, Risk, Sale, Growth, Therapy, Janssen Pharmaceuticals, Company, Registration statement, Merck & Co., Ownership, Special, Prospectus, Securities Act of 1933, SEC, Compte rendu, Form, U.S. Securities and Exchange Commission, Cancer, Patient, Private Securities Litigation Reform Act, Phrase, Amyotrophic lateral sclerosis, Merck, Proxy statement, FTLD, Johnson & Johnson, Muscle atrophy, Toxicity, Register, PIPE, GLOBE, VISTA, Nature, CBI, Failure, Proxy, ALS, Neurodegeneration, Security (finance), Pharmaceutical industry, Property management, Holding company, Nasdaq, Janssen, Kineta, Shareholder, Yuman–Cochimí languages

Yumanity will mail the definitive proxy statement/prospectus (the Proxy Statement) to stockholders of record as of the close of business on November 4, 2022.

Key Points: 
  • Yumanity will mail the definitive proxy statement/prospectus (the Proxy Statement) to stockholders of record as of the close of business on November 4, 2022.
  • This press release may be deemed to be solicitation material with respect to the proposed transactions between Yumanity and Kineta and between Yumanity and Janssen.
  • In connection with the proposed transactions, on August 29, 2022, Yumanity filed with the U.S. Securities and Exchange Commission (the SEC) a registration statement on Form S-4 (the Initial Registration Statement), as amended by Amendment No.
  • 3 to the Initial Registration Statement filed with the SEC on November 4, 2022 (together with the Initial Registration Statement, the Registration Statement), which contains a preliminary proxy statement and prospectus.

Solid Biosciences Provides Third Quarter 2022 Business Update and Financial Results

Retrieved on: 
Thursday, November 10, 2022
Name, IND, HSV, Research, Sale, Family, ANY, Private placement, Company, Program, Security (finance), Capsid, SEC, U.S. Securities and Exchange Commission, Compliance, AAV, Patient, DMD, Drug discovery, Acquisition, European Medicines Agency, Reverse stock split, Investigational New Drug, Private Securities Litigation Reform Act, Mutation, BAG3, Nasdaq, Mouse, Efficiency, Duchenne muscular dystrophy, Public expenditure, EMA, Entrepreneurship, Proxy, FDA, GLOBE, IGNITE, NOS1, Investment, Safety, Shareholder, Disease, Animal, Natural history, Pharmaceutical industry, Vaccine, Video game, Duchenne, Solid

CHARLESTOWN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today reported financial results for the third quarter ended September 30, 2022 and provided a business update.

Key Points: 
  • In October 2022 , Solid presented new SGT-003 preclinical data which demonstrated increased microdystrophin expression using AAV-SLB101 compared to AAV9.
  • There were no collaboration revenues for the third quarter of 2022, compared to $3.5 million for the third quarter of 2021.
  • Research and development expenses for the third quarter of 2022 were $14.0 million, compared to $14.4 million for the third quarter of 2021.
  • Net loss for the third quarter of 2022 was $20.4 million, compared to $18.0 million for the third quarter of 2021.

Constellation Brands’ Stockholders Approve Previously Announced Elimination of Class B Common Stock

Retrieved on: 
Wednesday, November 9, 2022
Constellation, GLOBE, Review, Love, Wine, Common stock, Constellation Brands, NYSE, U.S. Securities and Exchange Commission, Risk, Communication, Grupo Modelo, Board, Corona (beer), CPG, Annual report, Failure, Compte rendu, Rotation, New, Company, CEO, Security (finance), Board of directors, Beer, Certification, Holding company, Shareholder

VICTOR, N.Y., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Constellation Brands (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced that its stockholders approved and adopted at a special meeting held this afternoon an amended and restated charter, which will effectuate the previously announced elimination of Constellations Class B Common Stock.

Key Points: 
  • VICTOR, N.Y., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Constellation Brands (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced that its stockholders approved and adopted at a special meeting held this afternoon an amended and restated charter, which will effectuate the previously announced elimination of Constellations Class B Common Stock.
  • Following completion of the transaction and cessation of trading in the Class B Common Stock, Constellations publicly listed stock will consist of a single class of Class A Common Stock, with one share, one vote rights.
  • Constellation currently anticipates that the reclassification will be completed prior to the opening of trading on the New York Stock Exchange on November 10, 2022.
  • I want to thank our stockholders for their support and approval of this important transition to align the voting rights and economic interests of our common stock, said Bill Newlands, Constellations President and CEO.

TC Energy declares quarterly dividends

Retrieved on: 
Wednesday, November 9, 2022
GLOBE, Board of directors, DRP, Carbon, Shareholder, Forward-looking statement, NYSE, TC Energy, Natural gas, TC, Board, TRP, Income Tax Act, Annual report, U.S. Securities and Exchange Commission, Treasury, Company, Program, Hydrogen, TSX, Section 50C of the Isle of Man Income Tax Act 1970, News, SEDAR, Donald Duck filmography, Holding company, Renewable energy, Security (finance)

CALGARY, Alberta, Nov. 09, 2022 (GLOBE NEWSWIRE) -- News Release TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) today announced that its Board of Directors (Board) declared a quarterly dividend of $0.90 per common share for the quarter ending Dec. 31, 2022, on the Companys outstanding common shares.

Key Points: 
  • CALGARY, Alberta, Nov. 09, 2022 (GLOBE NEWSWIRE) -- News Release TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) today announced that its Board of Directors (Board) declared a quarterly dividend of $0.90 per common share for the quarter ending Dec. 31, 2022, on the Companys outstanding common shares.
  • Under the DRP, investors holding TC Energy common or preferred shares can receive common shares instead of cash dividend payments.
  • Were a team of 7,000+ energy problem solvers working to move, generate and store the energy North America relies on.
  • Forward-looking statements in this document are intended to provide TC Energy security holders and potential investors with information regarding TC Energy and its subsidiaries, including management's assessment of TC Energy's and its subsidiaries' future plans and financial outlook.

Conformis, Inc. Effects 1-for-25 Reverse Stock Split

Retrieved on: 
Wednesday, November 9, 2022
Transfer, Director, GLOBE, Reverse stock split, Nasdaq, Book, Patent, Arthralgia, Health, Dipterocarpus conformis, Private Securities Litigation Reform Act, Board, AST, CUSIP, Annual report, NASDAQ, Coronavirus, Solution, Board of directors, Cyprus Securities and Exchange Commission, U.S. Securities and Exchange Commission, Compliance, Shareholder, Joint, CFMS, Growth, Security (finance)

As a result of the Reverse Stock Split, each 25 shares of Conformis' common stock outstanding will be combined into one share of common stock and the total number of shares of common stock outstanding will be reduced from approximately 188 million shares to approximately 7.5 million shares.Stockholders of record will receive cash in lieu of any fraction of a share that stockholders would otherwise be entitled to receive as a result of the Reverse Stock Split.

Key Points: 
  • As a result of the Reverse Stock Split, each 25 shares of Conformis' common stock outstanding will be combined into one share of common stock and the total number of shares of common stock outstanding will be reduced from approximately 188 million shares to approximately 7.5 million shares.Stockholders of record will receive cash in lieu of any fraction of a share that stockholders would otherwise be entitled to receive as a result of the Reverse Stock Split.
  • Conformis has retained American Stock Transfer & Trust Company (AST) to act as exchange agent for the reverse stock split.
  • AST will manage the exchange of old, pre-reverse stock split shares for new post-reverse stock split shares.
  • Stockholders owning shares through a bank, broker, or other nominee will have their positions automatically adjusted to reflect the Reverse Stock Split, subject to brokers particular processes, and will not be required to take any action in connection with the Reverse Stock Split.